This group comprises agents, which inhibit fibrinolytic activity.
Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.
|The DDDs are based on treatment of hemorrhage associated with fibrinolysis.|
B02AB Proteinase inhibitors
Combinations with aprotinin used as local hemostatics are classified in B02BC30.
Last updated: 2016-12-19